Patent · US Active

Compositions and methods of enhancing immune responses

US8604178B2 · kind B2 · utility

31Cited by
24References
27Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 18, 2007
Grant dateDec 10, 2013
Priority date
Expiry dateJun 4, 2029

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are Salmonella enteritidis 13A strains and compositions comprising these strains. Also provided are methods of enhancing an immune response against Influenza A and methods of reducing morbidity associated with an Influenza A infection. Methods of enhancing an immune response to a vaccine vector by expressing a polypeptide of CD 154 capable of binding CD40 are also disclosed. Methods of developing a bacterial vaccine vector are disclosed. Methods of generating scarless site-specific mutations in a bacterium are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.